Gene therapy Conferences and Events

Gene therapy aims to treat or prevent disease by adding, replacing, silencing, repairing, or regulating genetic information in cells. It can use viral vectors, nonviral nanoparticles, genome-editing tools, RNA-based approaches, or engineered cells to deliver therapeutic instructions. In biotechnology and nanomedicine, gene therapy depends heavily on safe and effective delivery, durable expression or editing, immune management, and precise targeting of tissues.

Gene therapy matters because it offers the possibility of treating disease at its genetic cause rather than only managing symptoms. Applications include rare inherited disorders, cancer, blood diseases, eye diseases, neurological disorders, and immune conditions. Key challenges include vector capacity, biodistribution, immune response, off-target effects, manufacturing, long-term follow-up, cost, and access. The field connects closely to gene delivery, CRISPR delivery, RNA therapeutics, and cell therapy.

Conferences on gene therapy appear in biotechnology, medicine, pharmaceutical science, genome editing, nanomedicine, and clinical translation programs. Sessions often cover viral vectors, nonviral delivery, in vivo editing, regulatory science, manufacturing, and patient outcomes. Tracking gene-therapy events helps researchers follow a transformative field where genetic tools are being translated into durable therapeutic strategies.

To learn more, read our detailed glossary article on gene therapy.